United States: Adding To The U.S.'s COVID-19 Vaccine Arsenal, FDA Issues EUA For Novavax – Will It Impact Religious Accommodations? - Seyfarth Shaw LLP

Seyfarth Synopsis: On July 13, 2022, the U.S. Food and Drug Administration ("FDA") issued an emergency use authorization ("EUA") for the Novavax COVID-19 Vaccine, Adjuvanted.